Protective measures for COVID-19 for healthcare providers and laboratory personnel
Protective measures for COVID-19 for healthcare providers and laboratory personnel
In the COVID-19 pandemic, which affects the whole world, healthcare professionals (HCP) are at high risk of transmissiondue to their direct contact with patients with COVID-19. Therefore, how to ensure the triage of the patient with acute respiratorysymptoms should be determined in advance, the contact distance should be arranged to be at least 2 m, COVID-19 suspect or diagnosedpatient should be instructed to wear a surgical mask. During the care of these patients, HCP should wear their personal protectiveequipment (PPE) in accordance with the procedure and should not neglect hand hygiene. The samples of the patient with known orsuspected COVID-19, patient should also be known to be risky in terms of contamination, and a risk assessment should be performedfor the procedures to be performed in laboratories. The PPE should be used in accordance with the procedure to be performed. Theprotection of the HCP, who sacrifice at the risk of life, is possible only by complying with infection control and precautions.
___
- 1. European Centre for Disease Prevention and Control. Novel
coronavirus disease 2019 (COVID-19) pandemic: increased
transmission in the EU/EEA and the UK–sixth update.
Stockholm, Sweden: ECDC; 2020.
- 2. Public Health England. Guidance.Transmission characteristics
and principles of infection prevention and control. Updated 3
April 2020. London, UK: PHE; 2020.
- 3. Doremalen NV, Bushmaker T, Morris DH, Holbrook MG,
Gamble A et al. Aerosol and surface stability of HCoV-19
(SARS-CoV-2) compared to SARS-CoV-1. New England
Journal of Medicine 2020; 382: 1564-1567. doi: 10.1056/
NEJMc2004973
- 4. Zhang Z, Liu S, Xiang M, Li S, Zhao D et al. Protecting
healthcare personnel from 2019-nCoV infection risks: lessons
and suggestions. Frontiers of Medicine 2020. doi:101007/
s11684-020-0765-x
- 5. Wang D, Hu B, Hu C, Zhu F, Liu X et al. Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirusinfected
pneumonia in Wuhan, China. JAMA 2020; 323 (11):
1061-1069. doi: 101001/jama20201585
- 6. Centers for Diseases Control and Prevention. Interim Infection
Prevention and Control Recommendations for Patients
with Suspected or Confirmed Coronavirus Disease 2019
(COVID-19) in Healthcare Settings. Atlanta, Georgia, USA:
CDC; 2020.
- 7. European Centre for Disease Prevention and Control. Infection
prevention and control for COVID-19 in healthcare settings
12 March 2020. ECDC Technical Report. Stockholm, Sweden:
ECDC; 2020.
- 8. Novel Coronavirus 2019 (COVID-19). Nationa linterim
guidelines for public health management of contacts of cases
of COVID-19; 2020.
- 9. Tan SS, Yan B, Saw S, Lee CK, Chong AT et al. Practical
laboratory considerations amidst the COVID-19 outbreak:
early experience from Singapore. Journal of Clinical Pathology
2020: 01-4. doi: 101136/jclinpath-2020-206563
- 10. World Health Organization. Infection prevention and control
during health care when COVID-19 is suspected: interim
guidance 19 March 2020. Geneva, Switzerland: WHO; 2020.
- 11. Malhotra N, Gupta N, Ish S, Ish P. COVID-19 in intensive
care. Some necessary steps for health care workers. Archives
for Chest Diseases 2020; 90 (1): 20201284. doi: 10.4081/
monaldi.2020.1284
- 12. Tran K, Cimon K, Severn M, Carmem L. Pessoa-Silva CL et
al. Aerosol generating procedures and risk of transmission of
acute respiratory infections to healthcare workers: a systematic
review. PLoS One 2012; 7(4): e35797
doi: 10.1371/journal.pone.0035797
- 13. Ferioli M, Cisternino C, Leo V, Pisani L, Palange P et al.
Protecting healthcare workers from SARS-CoV-2 infection:
practical indications. European Respiratory Review 2020; 29:
200068 doi: 101183/160006170068-2020
- 14. Public Health England. Guidance. Reducing the risk of
transmission of COVID-19 in the hospital setting Updated 7
April 2020. London, UK: PHE; 2020.
- 15. Centers for Diseases Control and Prevention. Interim U.S.
guidance for risk assessment and public health management
of healthcare personnel with potential exposure in a healthcare
setting to patients with Coronavirus Disease (COVID-19).
Atlanta, Georgia, USA: CDC; 2020.
- 16. Republic of Turkey Ministry of Health. Public health general
directorate. COVID-19 (SARS-CoV-2) infection guideline.
COVID-19 medical advisory committee study. Ankara,
Turkey: Republic of Turkey Ministry of Health; 2020.
- 17. Liang T. Handbook of COVID-19 Prevention and Treatment.
Hangzhou, China: Zhejiang University School of Medicine;
2020.
- 18. Seah I, Agrawal R. Can the coronavirus disease 2019
(COVID-19) affect the eyes? a review of coronaviruses
and ocular implications in humans and animals. Ocular
Immunology and Inflammation 2020; 28 (3): 391-395. doi:
101080/0927394820201738501
- 19. Health Protection Scotland. UK Coronavirus COVID-19
response. Infection prevention and control measures. Scotland:
HPS; 2020.
- 20. Public Health England. Guidance COVID-19 personal
protective equipment (PPE) Updated 7 April 2020. London,
UK: PHE; 2020.
- 21. World Health Organization. Clinical management of severe
acute respiratory infection (SARI) when COVID-19 disease
is suspected: interim guidance 13 March 2020. Geneva,
Switzerland: WHO; 2020.
- 22. ENTUK. Guidelines for changes in ENT during COVID-19
Pandemic. London: ENTUK; 2020.
- 23. Centers for Diseases Control and Prevention. Coronavirus
Disease 2019 (COVID-19). Strategies for optimizing the
supply of n95 respirators. Atlanta, Georgia, USA: CDC; 2020.
- 24. World Health Organization. Modes of transmission of
virus causing COVID-19: implications for IPC precaution
recommendations. Scientific brief. Geneva, Switzerland:
WHO; 2020.
- 25. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT et al. Air,
surface environmental, and personal protective equipment
contamination by severe acute respiratory syndrome
coronavirus 2 (sars-cov-2) from a symptomatic patient. JAMA
2020. doi:101001/jama20203227
- 26. Queensland Health. Interim infection prevention and control
guidelines for the management of COVID-19 in healthcare
settings. Version 1.10: 27 March 2020. Brisbane, Australia:
Queensland Health; 2020.
- 27. Wua YC, Chena CS, Chan YJ. The outbreak of COVID-19: An
overview. Journal of Chinese Medical Association; 83 (3): 217-
220. doi: 101097/JCMA0000000000000270
- 28. World Health Organization. Clinical management of severe
acute respiratory infection when novel coronavirus (2019-
nCoV) infection is suspected: interim guidance 13 March
2020. Geneva, Switzerland: WHO; 2020.
- 29. World Health Organization. Laboratory biosafety guidance
related to coronavirus disease 2019 (COVID-19) Interim
guidance 12 February 2020. Geneva, Switzerland: WHO; 2020.
- 30. World Health Organization. Laboratory testing for coronavirus
disease (COVID-19) in suspected human cases interim
guidance 19 March 2020. Geneva, Switzerland: WHO; 2020.
- 31. Health Protection Scotland. COVID-19 Guidance for sampling
and laboratory investigations Version 7.2. Scotland: HPS; 2020
- 32. COVID-19: protecting health-care workers. Lancet 2020; 395:
922.